Harvest Group Wealth Management, LLC Regenxbio Inc. Transaction History

Harvest Group Wealth Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 23, 2020	SELL	$21.5 - $54.2 $1,333 - $3,360	-62 Closed	0 $0
Q4 2019 Jan 27, 2020	BUY	$34.54 - $44.87 $2,141 - $2,781	62 New	62 $2,000
Q3 2019 Nov 01, 2019	SELL	$31.84 - $50.88 $1,018 - $1,628	-32 Closed	0 $0
Q1 2019 May 06, 2019	BUY	$40.82 - $62.45 $1,306 - $1,998	32 New	32 $2,000

195

42.9M

104K

478K

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $325M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

Get notified when there are updates to the investment portfolio of Harvest Group Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Harvest Group Wealth Management, LLC with notifications on news.